Found 21 matching trials
Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection PHASE3 Hepatitis C virus (HCV) infection is a leading cause of death and illness i...
Show More Learn More & Join Trial
A Collaborative Trial in Injectors of Individualized Treatment for Genotype 2/3 PHASE4 This sudy will determine whether shortening treatment for hepatitis C is fe...
Show More Location
Hunter Pharmacotherapy
Learn More & Join Trial
Effects of 48 Weeks Versus 24 Weeks of Therapy With Peg-Intron/Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 (Study P04143)(TERMINATED) PHASE4 This is an Australian, open-label, multicenter, randomized, double-blind cl...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of the Combination Vitamin D With Standard of Care in Egyptian Patients With Untreated Chronic Hepatitis C PHASE3 The purpose of this study is to show the superiority of a 4 weeks lead-in p...
Show More Learn More & Join Trial
HCV-HIV Co-infected Patient Cohort in Thailand PHASE4 This is a study of HCV treatment using the standard regimen of pegylated-in...
Show More Location
Sanpatong Hospital
Learn More & Join Trial
Phase 2B Dose Ranging Study of Locteron Plus Ribavirin to Treat HCV PHASE2 The purpose of the study was to assess in subjects with chronic hepatitis C...
Show More Learn More & Join Trial
Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin PHASE2 The majority of Human immunodeficiency Virus (HIV)/Hepatitis C Virus (HCV) ...
Show More Location
CHU Sainte Marguerite
Learn More & Join Trial
Efficacy of Prazosin Versus Placebo Associated With Peg-interferon Alpha 2b and Ribavirin in Chronic Hepatitis C With Genotype 1 or 4 and Severe Fibrosis PHASE2 Viral hepatitis C prognosis is related to the presence of a fibrosis and to...
Show More Location
Hopital du haut Leveque
Learn More & Join Trial
A Study of Albuferon and Ribavirin in Interferon Naive Subjects With Chronic Hepatitis C Genotype 1 PHASE2 The purpose of the study is to evaluate the efficacy and safety of Albufero...
Show More Location
Royal Prince Alfred Hospital
Learn More & Join Trial
Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C PHASE2 Viral hepatitis C is treated with peg-interferon alpha 2a/2b and ribavirin....
Show More Location
Hopital Haut Leveque Service d'Hepato-Gastro-Enterologie
Learn More & Join Trial